Drug Shortage Report for ONDANSETRON INJECTION, USP

Last updated on 2020-05-26 History
Report ID 114859
Drug Identification Number 02390051
Brand name ONDANSETRON INJECTION, USP
Common or Proper name ONDANSETRON INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ONDANSETRON
Strength(s) 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20ML 1VL
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-11
Estimated end date 2020-06-09
Actual end date 2020-05-25
Shortage status Resolved
Updated date 2020-05-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-05-26 French Compare
v3 2020-05-26 English Compare
v2 2020-05-12 French Compare
v1 2020-05-12 English Compare

Showing 1 to 4 of 4